On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding provided by the National Institutes of Health (NIH), to establish centers for immunology research to accelerate progress in tuberculosis (TB) vaccine development.

New and improved TB vaccines are badly needed. Over the past 200 years, TB has claimed the lives of more than 1 billion people—more deaths than from malaria, influenza, smallpox, HIV/AIDS, cholera and plague combined.